MATCHING-ADJUSTED INDIRECT COMPARISON OF UPADACITINIB VERSUS USTEKINUMAB ON ENDOSCOPIC OUTCOMES AMONG PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Christopher Ma  1     Marla C. Dubinsky  2     Jordan Axelrad  3     Samuel Anyanwu  4     Jacinda Tran  4, 5     Namita Joshi  5     Jenny Griffith  5    
1 University of Caglary, Calgary, Canada
2 Icahn School of Medicine, Mount Sinai, New York City, United States
3 NYU Grossman School of Medicine, New York, United States
4 AbbVie, Inc, North Chicago, United States
5 University of Washington, Seattle, United States

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing